ALENDRONIC ACID, SODIUM

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 23 USDMF, 13 CEP/COS, 6 JDMF, 12 EU WC, 4 KDMF, 10 NDC API, 22 Listed Suppliers

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers, 64 FDA Orange Book, 230 Europe, 21 Canada, 14 Australia, 3 South Africa, 29 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 70MG BASE, TABLET;ORAL - EQ 70MG BASE;2,800 IU, TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 18 SPI Pharma, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 3 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 6 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 2 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 BASF, 1 Bioplus Life Sciences, 7 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures, 5 Ingredion Pharma Solutions, 15 Kerry, 3 Keval Exports, 3 Lonza Capsugel, 12 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 18 Roquette, 1 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

57 Fillers, Diluents & Binders, 33 Direct Compression, 27 Disintegrants & Superdisintegrants, 24 Granulation, 24 Taste Masking, 17 Chewable & Orodispersible Aids, 16 Thickeners and Stabilizers, 15 Co-Processed Excipients, 14 Lubricants & Glidants, 8 Parenteral, 8 API Stability Enhancers, 8 Empty Capsules, 6 Coating Systems & Additives, 4 Controlled & Modified Release, 4 Solubilizers, 3 Emulsifying Agents, 3 Topical, 2 Rheology Modifiers, 1 Film Formers & Plasticizers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 25 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 60 Regulatory FDF Prices

MARKET PLACE

10 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 JP, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

FILTER :

filter Order Code Reset all filters

2 All

01 1Y0001678

02 1Y0001727

filter CAS Number Reset all filters

filter Reference Standard Reset all filters

Reset Filter

Price Info

Product Main Page

01

EDQM, Council of Europe

Sodium alendronate trihydrate

CPhI Japan

Not Confirmed

02

EDQM, Council of Europe

Sodium alendronate for system suitabilit...

CPhI Japan

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

ALENDRONIC ACID, SODIUM

ALENDRONIC ACID, SODIUM

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

55 API Suppliers

23 USDMF

13 CEP/COS

6 JDMF

12 EU WC

4 KDMF

10 NDC API

22 Listed Suppliers

DEVELOPMENTS

14 Drugs in Development

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers

64 FDA Orange Book

230 Europe

21 Canada

14 Australia

3 South Africa

29 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 70MG BASE

TABLET;ORAL - EQ 70MG BASE;2,800 IU

TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc

18 SPI Pharma

1 Pharm-RX Chemical

3 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

2 Pfanstiehl

3 Kirsch Pharma

1 Cerata Pharmaceuticals LLP

6 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

2 Actylis

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 BASF

1 Bioplus Life Sciences

7 DFE Pharma

5 Gangwal Chemicals

1 Ideal Cures

5 Ingredion Pharma Solutions

15 Kerry

3 Keval Exports

3 Lonza Capsugel

12 Microlex e.U

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qualicaps

18 Roquette

1 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

4 Silverline Chemicals

1 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

57 Fillers, Diluents & Binders

33 Direct Compression

27 Disintegrants & Superdisintegrants

24 Granulation

24 Taste Masking

17 Chewable & Orodispersible Aids

16 Thickeners and Stabilizers

15 Co-Processed Excipients

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 35MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons